Proteonomix Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Michael Cohen
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 14.1yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 16.3yrs |
Recent management updates
No updates
Recent updates
No updates
CEO
Michael Cohen (57 yo)
14.1yrs
Tenure
US$365,000
Compensation
Mr. Michael Cohen serves as Chairman, President and Chief Executive Officer of Proteonomix Inc. (formerly, National Stem Cell Inc) and has been its Treasurer since August 2010. Mr. Cohen has been Chief Fin...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | no data | US$365.00k | no data | |
| CTO & Director | 16.2yrs | no data | no data | |
| Scientific Advisor | 16.3yrs | no data | no data | |
| Scientific Advisor | 16.3yrs | no data | no data | |
| Scientific Advisor | 15.8yrs | no data | no data |
16.3yrs
Average Tenure
57yo
Average Age
Experienced Board: PROT's board of directors are seasoned and experienced ( 16.3 years average tenure).